Delivery Order 36F79724D0119-36C24525N0734
Award Date
6/24/25
Potential Completion Date
6/26/25
Potential Value
$10K
Federal Agency
Veterans Integrated Service Network 5
Awardee
Insmed Inc.
Ultimate Awardee
Not listed
NAICS Category
325412 - Pharmaceutical Preparation Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Carrollton, TX 75010, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Veterans Integrated Service Network 5 (VISN 5), a civilian agency under the U.S. Department of Veterans Affairs (VA), to Insmed Inc. The $10,105.40 firm fixed-price delivery order is for the supply of ARIKAYCE (amikacin) 590mg/8.4ml, a pharmaceutical product used to treat non-tuberculous mycobacterial lung infections in veterans. The contract has no set-aside designation and is part of Insmed's existing federal supply schedule contract with the VA...
This is a delivery order awarded by the Department of Veterans Affairs (VA) to Insmed Inc., a global biopharmaceutical company, for the provision of emergency pharmacy orders. The order, valued at $70,737.80, is for firm fixed-price pharmaceutical products to be delivered by September 30, 2025. The contract is not set aside for any particular business type. Insmed Inc. holds multiple federal contract vehicles with the VA, including a GSA Pharmaceutical and Drugs schedule contract, which allows...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 2 issued a $15,442.08 delivery order against the Pharmaceuticals and Drugs Federal Supply Schedule contract (FSS-61-IB) to Insmed Incorporated for an emergency supply of ARIKAYCE (AMIKACIN LIPOSOME) INHALATION SUSPENSION 28 day packs. As the prime contractor, Insmed will deliver the liposomal amikacin inhalation medication to aid in the treatment of nontuberculous mycobacterial lung infections...
This is a federal delivery order contract awarded by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of ARIKAYCE 590 MG/8.4 ML VIAL 8.4ML, a specialty pharmaceutical product. The contract has a ceiling value of $15,308.51 and runs through October 9, 2024. This appears to be a task order or delivery order off a larger Indefinite Delivery Contract (IDC) vehicle held by...
This is a firm fixed-price delivery order awarded by the Veterans Integrated Service Network 5, a civilian agency under the Department of Veterans Affairs, to Insmed Inc. for the drug BELZUTIFAN (WELIREG) 40 MG. The contract has a ceiling value of $10,105.41 and a completion date of February 17, 2025. Insmed Inc. is a global biopharmaceutical company that provides pharmaceuticals and drugs to the VA, including the antibiotic amikacin and the drug ARIKAYCE for the treatment of nontuberculous...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of ARIKAYCE 590 MG/8.4 ML VIAL 8.4ML, a pharmaceutical product, with a ceiling value of $16,395.42 and a performance period through April 9, 2025. The contract is a firm fixed-price delivery order, and there is no set-aside designation indicated. AmerisourceBergen holds a $999,999,999...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical, a defense agency, to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,941.36 firm fixed-price delivery order is for the pharmaceutical product INBRIJA 42 MG INHALATION CAP 60S. The contract has an ultimate completion date of January 27, 2025. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen...
This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is for the delivery of the pharmaceutical product INBRIJA 42 MG INHALATION CAP 60S, with a ceiling value of $1,251.00 and a period of performance through April 2, 2024. The contract does not have a set-aside designation. AmerisourceBergen Drug Corp, a for-profit organization, is the...
This is a delivery order awarded by the Department of Veterans Affairs (VA) Veterans Health Administration (VHA) Veterans Integrated Service Network 12 to Acorda Therapeutics, Inc., a biotechnology company that develops and commercializes neurological therapies. The $493,607.04 firm fixed-price delivery order is for the supply of Levodopa 42mg inhalers, which are used to treat Parkinson's disease symptoms. This delivery order is issued under Acorda Therapeutics' Federal Supply Schedule (FSS)...
This is a firm fixed-price Blanket Purchase Agreement (BPA) call issued by the Department of Veterans Affairs (VA) Veterans Integrated Service Network 7 (VISN 7) to Ariad Pharmaceuticals, Inc. for the order of pharmaceuticals, specifically cancer drugs such as Iclusig (ponatinib) and Lenvima (lenvatinib), for the Department of Veterans Affairs in fiscal year 2017. The contract has a ceiling value of $108,039.90 and an ultimate completion date of September 30, 2017. This contract was awarded...